StonvexLoading…
StonvexStonvexStonvexCore line items from SRPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.86B | $1.79B | $1.14B | $843.77M |
Operating Income | $-699.78M | $218.08M | $-267.82M | $-536.20M |
Net Income | $-713.41M | $235.24M | $-535.98M | $-703.49M |
EPS (Diluted) | $-7.13 | $2.34 | $-5.80 | $-8.03 |
Total Assets | $3.35B | $3.96B | $3.26B | $3.13B |
Total Liabilities | $2.21B | $2.44B | $2.41B | $2.74B |
Cash & Equivalents | $801.28M | $1.10B | $428.43M | $966.78M |
Free Cash Flow OCF − CapEx | $-307.45M | $-342.74M | $-577.10M | $-356.17M |
Shares Outstanding | 104.96M | 96.90M | 93.73M | 87.95M |